SOL Global’s Heavenly Rx to Merge With Therapix Biosciences
SOL Global (CSE: SOL) announced this morning that their 40.7% owned portfolio company Heavenly Rx will be completing a reverse
Read moreSOL Global (CSE: SOL) announced this morning that their 40.7% owned portfolio company Heavenly Rx will be completing a reverse
Read more